期刊文献+

伴t(8;21)(q22;q22)易位的儿童急性双表型白血病的生物学特征 被引量:3

The biological characteristics of biphenotypic acute leukemia with t(8;21)(q22;q22) in children
原文传递
导出
摘要 目的探讨伴t(8;21)(q22;q22)易位的儿童急性双表型白血病(BAL)的生物学特征。方法分析7例伴t(8;21)(q22;q22)易位的儿童BAL,取同期诊断的30例t(8;21)阴性的急性髓细胞性白血病(AML)患儿作为对照组,分析其骨髓细胞形态学、细胞免疫学表型、细胞遗传学、分子生物学(MICM)特征。结果 7例伴t(8;21)(q22;q22)易位的儿童BAL占同期连续190例急性髓细胞性白血病(AML)的3.7%。骨髓细胞形态学均显示为AML-M2,分类中原始细胞均显著增多(均P<0.01);免疫表型均为髓细胞系伴B淋巴细胞系表达;CD34为高表达阳性;均有t(8;21)(q22;q22)染色体改变,且常伴有染色体复杂易位或缺失等改变;融合基因AML1/ETO检测均为阳性;7例患儿经治疗后完全缓解(CR)率71.4%,对兼顾AML和急性淋巴细胞白血病(ALL)的联合治疗方案效果较好。结论 BAL是急性白血病的一种亚型,其预后不良可能与染色体异常发生率高、CD34高表达阳性有关,对于BAL采用兼顾AML和ALL的联合治疗方案可提高其疗效。 Objective To investigate the biological (BAL) with t( 8 ;21 ) ( q22 ; q22) in children. Methods characteristics of biphenotypic acute leukemia The characteristics of cellmorphology, immuno- phenotypes, chromosome karyotype and molecular biology of 7 cases of childhood BAL with t ( 8 ; 21 ) (q22;q22) were analyzed. The control group included 30 cases of acute myeloid leukemia(AML) with- out t(8 ;21 ) translocation detected during same period. Results The percentage of BAL with t (8;21) (q22 ;q22) in the 190 eases of the AML was 3.7% (7/190) . The BAL with t(8 ;21 ) of which the ex- pression was t (8 ;21 )(q22;q22) that the bone marrow cell morphology showed the AML -M2. The ini- tial cells all increasd evidently in the classification( all P 〈 0.01 ). The immunophenotypes were all in the category of the expressions of the myeloid markers with B-lymphoid. CD34 had high expression of positivi- ty. There were changes of the chromosomal with t (8 ;21 ) (q22 ;q22)also with the complexly depletion or translocation. The detection results of the confluent genes AML1/ETO were positive. The total complete remission (CR) rate was 71.4%. It achieved good response to combined chemotherapy targeting to both myeloid and lymphocytic leukemia. Conclusion BAL is a rare type of acute leukemia. The unfavorableindicators of BAL may be concerned abnormal karyotypes, high expression of positivity of CD34. Com- bined chemotherapy targeting to both myeloid and lymphocytic leukemia contribute to improving survival.
出处 《苏州大学学报(医学版)》 CAS 2012年第3期386-389,416,共5页 Suzhou University Journal of Medical Science
关键词 儿童 急性髓细胞性白血病 免疫表型 t(8 21)易位 急性双表型白血病 children acute myeloid leukemia immunophenotype t(8 21 ) BAL
  • 相关文献

参考文献7

  • 1Lee JH, Min YH, Chung CW. et al. Prognostic implica- tions of the immunophenelype in biphenotypic acute leuke- mia [ J ]. Leuk Lymphoma, 2008,49 (4) :700 - 709.
  • 2Bene MC, Bemier M, Casasnovas RO,et al. The reliability and specificity of C-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias: the European Group for the Immunological Classification of Leukemias (EGIL) [J]. Blood, 1998, 92(2) :596 -599.
  • 3Kozlova I, Kevin Beasona, Cheng Yub,et al. CD79a ex- pression in acute myeloid leukemia t ( 8 ; 21 ) and the im- portance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity [ J ]. Cancer Genet Cytogeneties,2005,163 ( 1 ) :62 - 67.
  • 4何广胜,周玲,吴德沛,薛永权,朱明清,刘丹丹,孙爱宁,金正明,仇惠英,苗瞄,唐晓文,傅铮铮,马骁,王秀丽.染色体t(8;21)急性髓系白血病cCD79a/cCD22的异常表达[J].中华血液学杂志,2006,27(3):187-189. 被引量:3
  • 5潘湘涛,夏学鸣,李建勇,薛永权,过学,耿美菊,王爱清,朱明清,陈黎.M_2/t(8;21)的免疫学和遗传学特征及其与预后的关系[J].临床内科杂志,2002,19(2):133-135. 被引量:6
  • 6Miyamoto T, Weissman IL, Akashi K. AML1-ETO-ex- pressing nonleukemic stem cells in acute myelogenous leu- kemis with 8:21 chromosomal translocation [ J ]. Proc Natl Acad Sci USA, 2000,97(13) :7521 -7526.
  • 7Miyamoto T, Nagafuji K, Akashi K, et al. Persistence of multipotent progenitors expressing AML1/ETO transcropts in long-term remission patients with t (8 ;21 ) acute myelogenous leukemia[J]. Blood, 1996, 87(11) ;4789 -4796.

二级参考文献11

  • 1石培民,何广胜,吴德沛,耿美菊,朱明清,薛永权,阮长耿.成人急性双表型白血病MIC分型及临床特征研究[J].江苏医药,2004,30(10):792-793. 被引量:2
  • 2[1]Kita K,Nakase K,Miwa H,et al.Phenotypical characteristic of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality;frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.Blood,1992,80:470-477.
  • 3[2]Hurwitz CA,Raimodi SC,Head D,et al.Distinctive immunophenothic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.Blood,1992,80:3182-3188.
  • 4[3]Fourth International workshop on chromosome in leukemia 1982.Cancer Genet Cytogenet,1984,11:265-275.
  • 5[4]Felicetto F,Rosa N,Mario A,et al.Immunophenotypic analysis enables the correct prediction of t(8;21) in acute myeloid leukemia.Br J Haematol,1998,102:444-448.
  • 6[5]Solary E,Casasnovas QO,Canpos L,et al.Surface markers in adult acute myeloblastic leukemia:correction of CD19+,CD34+ and CD14+/DR-phenotypes with shorters survival.Group d'Etude Immunological des leucemies (GEIL).Leukemia,1992,6:393-398.
  • 7[6]Ball ED,Davis RB,Griffin JD,et al.Prognostic Value of lymphocytic surface markers in acute myeloid leukemia.Blood,1991,77:2222-2250.
  • 8[7]Porwit-MacDonald A,Janossy G,Ivory K,et al.Leukemia associatea changesidentified by quantitative flow cytometry.IV,CD34 overexpression in acute myelogenous Leukemia M2 with t(8;21).Blood,1996,87:1162-1172.
  • 9Miyamoto T,Nagafuji K,Akashi K,et al.Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t (8; 21) acute myelogenous leukemia.Blood,1996,87:4789-4796.
  • 10Miyamoto T,Weissman IL,Akashi K.AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8; 21 chromosomal translocation.Proc Natl Acad Sci U S A,2000,97:7521-7526.

共引文献6

同被引文献28

  • 1Owaidah TM,Al Beihany A,Iqbal MA,et al.Cytogenetics,molecular and ultra-structural characteristics of bipheno-typic acute leukemia identified by the EGIL scoring system.Leukemia,2006;20(4):620-626.
  • 2Yu L,JC R,Chen C,et al.Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia.Leukemia,2011;25(2):367-371.
  • 3Weir EG,Ali Ansari-Lari M,Batista DA,et al.Acute bilineal leukemia:a rare disease with poor outcome.Leukemia,2007;21:(22)64-70.
  • 4Katsura Y.Redefinition of lymphoid progenitors.Nature Rev Immunol,2002;2:(1)27-32.
  • 5Zulfikar OB,Koc BCAB,Kebudi R,et al.The outcome of acute biphenotypic leukemias in childhood:A single center experience.Journal of Clinical Oncology,2013;31(15)136-139.
  • 6He G,Wu D,Sun A,et al.B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22).Int J Hematol,2008;87:(13)2-6.
  • 7Miyamoto T,Weissman IL,Akashi K.AML/ETO1-expressing nonleukemia stem cells in acute myel-ogenous leukemia with t(8;21)chromosomal translocation.Proc Natl Acad Sci USA,2000;97:(75)21-26.
  • 8沈腾飞,薛清贵.成人急性双表型白血病的临床治疗和研究[J].中华肿瘤杂志,2012.24(4):211-214.
  • 9Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias (EGIL) [J]. Leukemia, 1995,9 (10) : 1783.
  • 10Yu L, Reader JC, Chen C, et al. Activation of a novel palmitoyltransfemse ZDHHC14 in acute biphenotypic leu- kemia and subsets of acute myeloid leukemia[J]. Leuke- mia,2011,25(2) :367-371.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部